Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Middle East and Africa Manufacturing Market Access

NGOs Say IP Barriers Must Be Overcome To Build Up Local Production Capacity

  • News

Executive Summary

The World Local Production Forum is being held this week amid wide-ranging discussions on how to give lower-resourced countries more self-sufficiency in medicines and vaccine manufacturing.

You may also be interested in...



EU & Africa CDC Strengthen Access & Local Manufacturing Collaboration

A new deal struck by the Africa CDC and the European Commission includes facilitating R&D into new health products and promoting technology transfer in Africa.

EU & Africa CDC Strengthen Access & Local Manufacturing Collaboration

A new deal struck by the Africa CDC and the European Commission includes facilitating R&D into new health products and promoting technology transfer in Africa.

Boost For South African Agency’s Regulatory Oversight Of Vaccine Manufacturing

The donation of equipment to SAHPRA may be a small step in the greater scheme of things, but every little helps when it comes to building up Africa’s self-sufficiency in vaccine production.

Table

View full table

Topics

Tags:
Middle East and Africa Manufacturing Market Access
Latest Headlines

Qualifying Digital Biomarkers ‘Much Easier Now’ Thanks To EMA Efforts

EMA Expands Early Engagement With Patients & Health Professionals

The Future Of US FDA’s Institutional Memory

Dry Eye Crossover Study Could Allow Aldeyra A Quick Response To US FDA’s CRL For Reproxalap

See All
UsernamePublicRestriction

Register

PS149313

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By